iTeos Therapeutics CEO Michel Detheux's 2020 pay jumps 964% to $17M

iTeos Therapeutics reports 2020 executive compensation

By ExecPay News

Published: May 5, 2021

iTeos Therapeutics reported fiscal year 2020 executive compensation information on May 5, 2021.
In 2020, three executives at iTeos Therapeutics received on average a compensation package of $6.7M, a 454% increase compared to previous year.
Average pay of disclosed executives at iTeos Therapeutics
Michel Detheux, Chief Executive Officer, received $17M in total, which increased by 964% compared to 2019. 95% of Detheux's compensation, or $16M, was in option awards. Detheux also received $121K in bonus, $243K in non-equity incentive plan, $463K in salary, as well as $7.5K in other compensation.
Matthew Gall, Chief Financial Officer, received a compensation package of $1.9M. 76% of the compensation package, or $1.4M, was in option awards.
Joanne Jenkins Lager, Chief Medical Officer, earned $1.3M in 2020, a 57% increase compared to previous year.

Related executives

Michel Detheux

iTeos Therapeutics

Chief Executive Officer

Joanne Lager

iTeos Therapeutics

Chief Medical Officer

Matthew Gall

iTeos Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on May 5, 2021.